Director, Cost Accounting
- Employer
- Dyne Therapeutics
- Location
- Waltham, MA
- Posted date
- Oct 8, 2026
View more categories
- Discipline
- Administration, Accounting
- Required Education
- Bachelors Degree
- Position Type
- Full time
- Hotbed
- Genetown
By clicking apply, your email address will be shared with the employer.
Job Details
Company Overview:
Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease. The company is advancing clinical programs for Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1) as well as preclinical programs for facioscapulohumeral muscular dystrophy (FSHD), Pompe disease and multiple DMD mutations. At Dyne, we are on a mission to deliver functional improvement for individuals, families and communities. Learn more at https://www.dyne-tx.com/, and follow us on X, LinkedIn and Facebook.
Role Summary:
The Director, Inventory / Cost Accounting leads Dyne’s inventory and cost accounting strategy and established the financial infrastructure required to support commercial launch and continued portfolio growth. This role owns the development, implementation and governance of cost accounting processes, inventory valuation, and related controls across clinical and commercial products manufactured through third-party CMOs and CDMOs.. The Director serves as the company’s subject matter expert for inventory and cost accounting, providing strategic guidance on product costs, capitalization, reserves, gross margin, and complex accounting judgments. This highly visible role influences business decisions by translating manufacturing and supply chain activity into clear financial insights and recommendations for senior leadership.
The Director partners closely with Supply Chain, Technical Operations, Commercial Operations, FP&A, external manufacturing partners, and auditors to ensure accurate, scalable, and audit-ready processes. This role sets priorities, directs cross-functional initiatives, and develops the capabilities and resources needed to support Dyne’s transition from clinical development to a multi-product commercial organization.
This is a full-time position based in Waltham, MA without the possibility of being remote.
Primary Responsibilities Include:
Cost Accounting & Costing Methodology
Develop, implement, and maintain cost models for commercial product(s) manufactured through third-party CMOs/CDMOs
Establish and maintain bill of materials (BOM) and routing cost structures in collaboration with Supply Chain and Technical Operations
Perform periodic cost updates and manufacturing/production variance analysis
Analyze and report on cost of goods sold (COGS)
Inventory Accounting
Own inventory accounting for raw materials, work-in-process, clinical supply, and finished goods held at third-party locations
Direct the period-end inventory and accounting close, ensuring accurate reporting, appropriate review, and timely resolution of issues
Manage inventory reserve methodology and perform periodic assessments
Manage physical inventory counts and cycle count programs across CMOs,CDMOs, and third-party logistics (3PL) providers
Determine and document appropriate accounting treatment for inventory used across clinical and commercial operations
CMO/CDMO Cost Management
Serve as the finance leader for cost-related aspects of CMO/CDMO relationships, including invoice review, cost true-ups, and technical transfer cost accounting
Partner with Supply Chain, Technical Operations, Commercial Operations, and FP&A to incorporate cost insights into operating plans, forecasts, launch decisions, and gross margin strategy.
Support cost impact analysis for manufacturing process changes, scale-up activities, and technology transfers
Financial Reporting & Controls
Establish and maintain a scalable control environment for inventory and cost accounting that complies with U.S. GAAP, SOX requirements, and public company standards
Prepare monthly, quarterly, and annual cost accounting analyses and reporting packages for FP&A and senior leadership
Design and maintain internal controls over inventory and cost accounting processes
Partner with the Corporate Controller on technical accounting memos related to inventory capitalization, cost absorption, and related judgments
Cross-Functional Partnership & Process Building
Act as a key finance partner to Supply Chain, Technical Operations, and Commercial Operations teams
Build scalable cost accounting processes, systems, and reporting tools appropriate for a growing commercial-stage company
Support ERP system configuration and enhancements related to cost accounting and inventory modules
Provide cost-related input to gross-to-net, gross margin analysis, and product profitability reporting
Education and Skills Requirements:
Bachelor's degree in Accounting, Finance, or related field; CPA required
10+ years of progressive cost accounting experience, including at least 3-5 years in a leadership/managerial capacity
Direct experience with cost accounting in a pharmaceutical, biotech, or life sciences manufacturing environment
Experience managing cost accounting for products manufactured through CMOs/CDMOs (outsourced manufacturing model)
Strong knowledge of U.S. GAAP as it relates to inventory, standard costing, and COGS
Experience with ERP systems (e.g., NetSuite) and cost accounting/inventory modules
Advanced Excel skills; experience building cost models
Experience supporting a commercial product launch and scaling cost accounting processes from a pre-commercial or early-commercial stage
Experience with SOX compliance and public company reporting requirements
Strong analytical and problem-solving skills; comfortable building processes from the ground up
Excellent cross-functional communication and ability to translate operational activity into financial impact
High attention to detail balanced with the ability to operate in ambiguity typical of an early-commercial company
#LI-Onsite
MA Pay Range
$200,000 - $230,000 USD
The pay range reflects the base pay range Dyne reasonably expects to pay for this role at the time of posting. Individual compensation depends on factors such as education, experience, job-related knowledge, and demonstrated skills.
The statements contained herein reflect general details as necessary to describe the principles functions for this job, the level of knowledge and skill typically required, and the scope of responsibility, but should not be considered an all-inclusive listing of work requirements. Individuals may perform other duties as assigned, including work in other functional areas to cover absences or relief, to equalize peak work periods or otherwise balance workload.
Dyne Therapeutics is an equal opportunity employer and will not discriminate against any employee or applicant on the basis of age, color, disability, gender, national origin, race, religion, sexual orientation, veteran status, or any classification protected by federal, state, or local law.
Company
Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases. With its proprietary FORCE™ platform, Dyne is developing modern oligonucleotide therapeutics that are designed to overcome limitations in delivery to muscle tissue. Dyne has a broad pipeline for serious muscle diseases, including clinical programs for myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD) and a preclinical program for facioscapulohumeral muscular dystrophy (FSHD). For more information, please visit https://www.dyne-tx.com, and follow us on X and Facebook.
Our mission to bring life-transforming therapies to people with serious muscle diseases is the foundation of our efforts and is driven by our exceptional team of Dynamos and their dedication to fostering an unparalleled culture. Watch the video to hear Dynamos share their perspectives on what makes Dyne a special place to work.
Stock Symbol: DYN
Stock Exchange: Nasdaq